Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals

Psychopharmacology

Volumn 234, Issue 15, 2017, Pages 2289-2297

  Passamonti, Luca ^a,b   Luijten, M ^c   Ziauddeen, H ^d   Coyle Gilchrist, I T S ^a   Rittman, T ^a   Brain, S A E ^a   Regenthal, R ^e   Franken, I H A ^f   Sahakian, B J ^g   Bullmore, E T ^g,h   Robbins, T W ^g   Ersche, K D ^g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d Cambridgeshire and Peterborough Foundation Trust   (United Kingdom)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Atomoxetine; Attentional bias; Cocaine addiction; Noradrenaline; Response inhibition

Indexed keywords

ATOMOXETINE; COCAINE; PLACEBO; ADRENERGIC RECEPTOR AFFECTING AGENT;

ADRENERGIC TRANSMISSION; ADULT; ARTICLE; ATTENTIONAL BIAS; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; VERBAL GO NOGO TASK; VERBAL MEMORY TEST; ASSOCIATION; ATTENTION; BLOOD; DRUG EFFECTS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHOTOSTIMULATION; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENERGIC UPTAKE INHIBITORS; ADULT; ATOMOXETINE HYDROCHLORIDE; ATTENTION; ATTENTIONAL BIAS; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; CUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 85019729110     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-017-4643-4     Document Type: Article

References (51)

1. Arnsten AF (2009) Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23(Suppl 1):33–41
2. Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309–1320
3. Bari A, Aston-Jones G (2013) Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. Neuropharmacology 64:53–64
4. Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44–79
5. Bari A, Mar AC, Theobald DE, Elands SA, Oganya KC, Eagle DM, Robbins TW (2011) Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci 31:9254–9263
6. Bosker WM, Neuner I, Shah NJ (2017) The role of impulsivity in psychostimulant- and stress-induced dopamine release: review of human imaging studies. Neurosci Biobehav Rev 78:82–90
7. Boyer M, Dickerson M (2003) Attentional bias and addictive behaviour: automaticity in a gambling-specific modified Stroop task. Addiction 98:61–70
8. Briand LA, Gritton H, Howe WM, Young DA, Sarter M (2007) Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol 83:69–91
9. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699–711
10. Cane JE, Sharma D, Albery IP (2009) The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues. J Psychopharmacol 23:510–519
11. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861–863
12. Chamberlain SR, Hampshire A, Muller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ (2009) Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 65:550–555
13. Cox WM, Fadardi JS, Pothos EM (2006) The addiction-stroop test: theoretical considerations and procedural recommendations. Psychol Bull 132:443–476
14. Dunning JP, Parvaz MA, Hajcak G, Maloney T, Alia-Klein N, Woicik PA, Telang F, Wang GJ, Volkow ND, Goldstein RZ (2011) Motivated attention to cocaine and emotional cues in abstinent and current cocaine users—an ERP study. Eur J Neurosci 33:1716–1723
15. Economidou D, Dalley JW, Everitt BJ (2011) Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biol Psychiatry 69:266–274
16. Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Muller U, Ooi C, Suckling J, Barnes A, Sahakian BJ, Merlo-Pich EV, Robbins TW (2010) Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Arch Gen Psychiatry 67:632–644
17. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET (2012) Abnormal brain structure implicated in stimulant drug addiction. Science 335:601–604
18. Field M, Marhe R, Franken IH (2014) The clinical relevance of attentional bias in substance use disorders. CNS Spectr 19:225–230
19. First MB (2002) The DSM series and experience with DSM-IV. Psychopathology 35:67–71
20. Fox H, Sinha R (2014) The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol 69:217–265
21. Fox H, Sofuoglu M, Sinha R (2015) Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals. J Psychopharmacol 29:312–323
22. Franken IH, Hendriksa VM, van den Brink W (2002) Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav 27:675–685
23. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652
24. Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T, Telang F, Alia-Klein N, Volkow ND (2007) Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144:1153–1159
25. Goldstein RA, DesLauriers C, Burda A, Johnson-Arbor K (2009) Cocaine: history, social implications, and toxicity: a review. Semin Diagn Pathol 26:10–17
26. Graf H, Abler B, Freudenmann R, Beschoner P, Schaeffeler E, Spitzer M, Schwab M, Gron G (2011) Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biol Psychiatry 69:890–897
27. Hester R, Dixon V, Garavan H (2006) A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug Alcohol Depend 81:251–257
28. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35:245–256
29. Kratochvil CJ, Vaughan BS, Harrington MJ, Burke WJ (2003) Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 4:1165–1174
30. Lapeyre-Mestre M, Dupui M (2015) Drug abuse monitoring: which pharmacoepidemiological resources at the European level? Therapie 70:147–165
31. Leeman RF, Robinson CD, Waters AJ, Sofuoglu M (2014) A critical review of the literature on attentional bias in cocaine use disorder and suggestions for future research. Exp Clin Psychopharmacol 22:469–483
32. Levin FR, Mariani JJ, Secora A, Brooks D, Cheng WY, Bisaga A, Nunes E, Aharonovich E, Raby W, Hennessy G (2009) Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial. J Dual Diagn 5:41–56
33. Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IH (2011) Neurobiological substrate of smoking-related attentional bias. NeuroImage 54:2374–2381
34. Marhe R, Luijten M, van de Wetering BJ, Smits M, Franken IH (2013) Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology 38:1085–1093
35. Marhe R, Luijten M, Franken IH (2014) The clinical relevance of neurocognitive measures in addiction. Front Psychiatry 4:185
36. Marissen MA, Franken IH, Waters AJ, Blanken P, van den Brink W, Hendriks VM (2006) Attentional bias predicts heroin relapse following treatment. Addiction 101:1306–1312
37. Nandam LS, Hester R, Wagner J, Cummins TD, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA (2011) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 69:902–904
38. Noel X, Van der Linden M, d’Acremont M, Colmant M, Hanak C, Pelc I, Verbanck P, Bechara A (2005) Cognitive biases toward alcohol-related words and executive deficits in polysubstance abusers with alcoholism. Addiction 100:1302–1309
39. Pintzinger NM, Pfabigan DM, Pfau L, Kryspin-Exner I, Lamm C (2016) Temperament differentially influences early information processing in men and women: preliminary electrophysiological evidence of attentional biases in healthy individuals. Biol Psychol
40. Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD (2012) Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 16:81–91
41. Ryan F (2002) Attentional bias and alcohol dependence: a controlled study using the modified stroop paradigm. Addict Behav 27:471–482
42. Sahgal A (1987) Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology 91:517–520
43. Schmidt KT, Weinshenker D (2014) Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors. Mol Pharmacol 85:640–650
44. Schmidt R, Luthold P, Kittel R, Tetzlaff A, Hilbert A (2016) Visual attentional bias for food in adolescents with binge-eating disorder. J Psychiatr Res 80:22–29
45. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33 quiz 34-57
46. Smith RJ, Aston-Jones G (2011) Alpha(2) adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Biol Psychiatry 70:712–719
47. Smith DG, Jones PS, Bullmore ET, Robbins TW, Ersche KD (2013) Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings. Transl Psychiatry 3:e257
48. Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 117(1):34–50
49. Walsh SL, Middleton LS, Wong CJ, Nuzzo PA, Campbell CL, Rush CR, Lofwall MR (2013) Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial. Drug Alcohol Depend 130:150–157
50. Waters AJ, Marhe R, Franken IH (2012) Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine. Psychopharmacology 219:909–921
51. Wiessing L (2005) European drugs agency highlights trends in drug use and problems affecting drug users. Euro Surveill 10:E051215 3